Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT03175172
Title Evaluation of CRS-207 With Pembrolizumab in Previously Treated MPM
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors Aduro Biotech, Inc.
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.